AKTIENANLEIHE - EXPRESS PROTECT - PFIZER INC Share Price

Certificat

DE000HVB80M1

Delayed Deutsche Boerse AG 11:03:46 23/05/2024 pm IST
89.24 EUR -1.27% Intraday chart for AKTIENANLEIHE - EXPRESS PROTECT - PFIZER INC
Current month+10.11%
1 month+8.45%
Date Price Change
23/24/23 89.24 -1.27%
22/24/22 90.39 +1.61%
21/24/21 88.96 -0.58%
20/24/20 89.48 +0.11%
17/24/17 89.38 -0.43%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 11:03 pm IST

More quotes

Static data

Product typeAktienanleihen
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HVB80M
ISINDE000HVB80M1
Date issued 01/08/2023
Strike 36.07 $
Maturity 27/07/2026 (795 Days)
Parity 0.04 : 1
Emission price 100
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 101
Lowest since issue 80.66
Spread 9
Spread %1.00%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
29.6 USD
Average target price
31.94 USD
Spread / Average Target
+7.90%
Consensus